Home> Products> stable glucose profile

{ "products": [ { "_id": "68134d097702eb2332e5ccb0", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLICLAGLAZE 40", "description": "GLICLAGLAZE 40 is an oral antidiabetic medication containing Gliclazide 40 mg, formulated to effectively manage Type 2 Diabetes Mellitus. It belongs to the class of drugs known as sulfonylureas, which are specifically designed to control blood glucose levels in adults who cannot manage diabetes through diet and exercise alone. By promoting insulin secretion and improving glycemic control, GLICLAGLAZE 40 helps prevent long-term complications associated with uncontrolled diabetes, such as nerve damage, kidney issues, and cardiovascular diseases.\n\nKey Ingredient\nGliclazide (40 mg):\nGliclazide is a second-generation sulfonylurea, known for its dual effect: stimulating insulin release from the pancreas and offering antioxidant properties. It not only lowers blood sugar but also provides vascular protection, making it suitable for patients at risk of cardiovascular events.\n\nKey Benefits\nEffectively reduces high blood sugar levels in Type 2 diabetes\n\nStimulates natural insulin secretion from pancreatic beta cells\n\nProvides cardiovascular protection by improving endothelial function\n\nMinimizes the risk of microvascular complications like retinopathy and nephropathy\n\nSuitable for long-term glycemic control when lifestyle measures are insufficient\n\nHelps maintain a stable glucose profile throughout the day\n\nHow Does It Work?\nGLICLAGLAZE 40 works by targeting the pancreas to enhance the secretion of insulin, which is essential for lowering blood glucose levels. Gliclazide binds to specific receptors on pancreatic beta cells, triggering the release of insulin in a glucose-dependent manner. This ensures that the medication works primarily when glucose levels are elevated, thus reducing the risk of hypoglycemia compared to older sulfonylureas. Additionally, its antioxidant properties contribute to improved vascular health, protecting blood vessels from oxidative damage often seen in diabetic patients.\n\nDirections for Use\nTake GLICLAGLAZE 40 exactly as prescribed by your healthcare provider\n\nUsually taken once or twice daily, preferably before meals\n\nSwallow the tablet whole with water — do not crush or chew\n\nMaintain a regular schedule for meals and medication to avoid hypoglycemia\n\nMonitor blood glucose levels regularly to track progress\n\nAlways combine with a balanced diet and exercise plan for optimal results\n\nSide Effects\nThough generally well-tolerated, GLICLAGLAZE 40 may cause some side effects:\n\nCommon Side Effects:\n\nHypoglycemia (low blood sugar)\n\nHeadache\n\nDizziness or light-headedness\n\nNausea or stomach discomfort\n\nWeight gain (in some patients)\n\nRare but Serious Side Effects:\n\nLiver enzyme abnormalities\n\nSkin rash or allergic reaction\n\nBlood disorders like anemia or thrombocytopenia\n\nVisual disturbances (usually temporary)\n\nSeek immediate medical attention if symptoms of severe hypoglycemia, such as confusion, fainting, or seizures, occur.", "price": 120.0, "discountamount": 34.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "gliclaglaze 40", "exercise plan", "balanced diet", "meals swallow", "nephropathy suitable", "gliclaglaze 40gliclaglaze 40", "seizures occur", "confusion fainting", "severe hypoglycemia", "medical attention", "temporary seek", "patients rare", "lightheadedness nausea", "track progress", "regular schedule", "daily preferably", "healthcare provider", "oxidative damage", "hypoglycemia compared", "glucosedependent manner", "specific receptors", "lifestyle measures", "microvascular complications", "secondgeneration sulfonylurea", "uncontrolled diabetes", "manage diabetes", "specifically designed", "chew maintain", "glucose levels", "cardiovascular protection", "promoting insulin secretion", "diabetic patients directions", "older sulfonylureas additionally", "medication works primarily", "oral antidiabetic medication", "stable glucose profile", "insufficient helps maintain", "vascular protection making", "thrombocytopenia visual disturbances", "antioxidant properties contribute", "longterm glycemic control", "pancreatic beta cells", "lowers blood sugar", "offering antioxidant properties" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2099, "imageuri": "https://productimages.withfloats.com/actual/68134d0b4b698d44a8c316f4.png", "tileimageuri": "https://productimages.withfloats.com/tile/68134d0b4b698d44a8c316f4.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-05-01T10:29:29.141Z", "updatedon": "2025-05-01T10:29:29.141Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/gliclaglaze-40/2099", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Gliclazide 40 mg", "category": "DIABETIC RANGE", "tags": [ "Gliclazide 40 mg uses in Hindi", "Gliclazide 40mg brands", "Gliclazide 40 mg price", "Gliclazide 40mg side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6661a2708da3a81d5c6a169f", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "STERIS SITAGLIPTIN 50 + METFORMIN 500 ", "description": "STERIS SITAGLIPTIN 50 + METFORMIN 500 \nSitagliptin (50mg) & Metformin HCI (500mg)\nIntroduction to STERIS SITAGLIPTIN 50 + METFORMIN 500\nSTERIS SITAGLIPTIN 50 + METFORMIN 500 is a combination medication that includes Sitagliptin 50mg and Metformin Hydrochloride 500mg. This medication is primarily used for the management of type 2 diabetes mellitus. By combining the complementary mechanisms of Sitagliptin and Metformin, this medication offers comprehensive glycemic control, helping patients effectively manage their blood sugar levels.\n\nWhat are Sitagliptin and Metformin?\nOverview of Sitagliptin\nSitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that helps control blood sugar levels by enhancing the body's ability to regulate insulin after meals. It works by inhibiting the DPP-4 enzyme, which results in prolonged activity of incretin hormones that play a significant role in glucose metabolism.\n\nOverview of Metformin\nMetformin is a biguanide that helps lower blood sugar levels by improving the body's sensitivity to insulin and reducing the amount of glucose produced by the liver. It also enhances peripheral glucose uptake and utilization. Metformin is a cornerstone in the management of type 2 diabetes due to its effectiveness and safety profile.\n\nBenefits of STERIS SITAGLIPTIN 50 + METFORMIN 500\nEffective Blood Sugar Management\nDual Mechanism of Action: Sitagliptin enhances insulin release and reduces glucagon levels after meals, while Metformin improves insulin sensitivity and reduces hepatic glucose production, providing comprehensive glycemic control.\nPostprandial and Fasting Glucose Control: This combination helps manage both postprandial (after-meal) and fasting blood sugar levels, offering all-around glycemic control.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: STERIS SITAGLIPTIN 50 + METFORMIN 500 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, this medication can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nAdditional Health Benefits\nWeight Management: Metformin is often associated with weight neutrality or modest weight loss, making it a favorable option for overweight or obese patients.\nLow Risk of Hypoglycemia: When used alone or in combination with Metformin, Sitagliptin has a low risk of causing hypoglycemia compared to some other diabetes medications.\nHow to Use STERIS SITAGLIPTIN 50 + METFORMIN 500\nDosage and Administration\nRecommended Dosage: The typical dosage is one tablet taken once or twice daily, depending on your healthcare provider's instructions. The dosage may be adjusted based on individual response and blood sugar levels.\nAdministration: Take the tablet with meals to reduce the risk of gastrointestinal discomfort and enhance the effectiveness of Metformin. Swallow the tablet whole with a full glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take the medication regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/steris-sitagliptin-50-metformin-500-134361", "price": 285.0, "discountamount": 85.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "Diet", "body", "liver", "Order", "EMAIL", "meals", "water", "amount", "Action", "option", "Support", "ability", "readings", "Low Risk", "Overview", "biguanide", "neuropathy", "one tablet", "overweight", "full glass", "Guidelines", "information", "Optimal Use", "utilization", "cornerstone", "retinopathy", "Adjustments", "Introduction", "Postprandial", "Reduced Risk", "best results", "sterisonline", "instructions", "DPP-4 enzyme", "Hypoglycemia", "sterispharma", "Metformin HCI", "effectiveness", "CALL/WHATSAPP", "Dual Mechanism", "Administration", "typical dosage", "obese patients", "Consistent Use", "treatment plan", "safety profile", "insulin release", "glucagon levels", "DPP-4) inhibitor", "significant role", "Sitagliptin 50mg", "Exercise Adjunct", "excellent adjunct", "incretin hormones", "weight neutrality", "Weight Management", "prolonged activity", "glucose metabolism", "STERIS SITAGLIPTIN", "Recommended Dosage", "modest weight loss", "blood sugar control", "insulin sensitivity", "Diabetes Management", "healthcare provider", "individual response", "combination medication", "cardiovascular disease", "dipeptidyl peptidase-4", "long-term complications", "lifestyle modifications", "Fasting Glucose Control", "Metformin Hydrochloride", "complementary mechanisms", "type 2 diabetes mellitus", "peripheral glucose uptake", "stable blood sugar levels", "other diabetes medications", "Additional Health Benefits", "hepatic glucose production", "gastrointestinal discomfort", "comprehensive glycemic control", "Effective Blood Sugar Management" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1468, "imageuri": "https://productimages.withfloats.com/actual/6661a271487c46164ce5354d.png", "tileimageuri": "https://productimages.withfloats.com/tile/6661a271487c46164ce5354d.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T11:50:08.381Z", "updatedon": "2024-06-29T05:37:18.286Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//steris-sitagliptin-50-metformin-500-/1468", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "STERIS SITAGLIPTIN 50 + METFORMIN 500 ", "category": "DIABETIC RANGE", "tags": [ "STERIS SITAGLIPTIN 50", "METFORMIN 500", "Sitagliptin (50mg)", "Metformin HCI (500mg)", "Metformin HCl", "Metformin side effects", "Metformin hydrochloride tablet uses", "Metformin Hydrochloride Tablets IP 500mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666185c2161afa2274ff4d10", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "SEIZMET GP 2 ", "description": "SEIZMET GP 2 \nGlimepiride (2mg), Metformin SR (500mg), Pioglitazone (15mg)\nIntroduction to SEIZMET GP 2\nSEIZMET GP 2 is a combination medication that includes Glimepiride 2mg, Metformin Hydrochloride Sustained Release (SR) 500mg, and Pioglitazone 15mg. This medication is primarily used for the management of type 2 diabetes mellitus. By combining the complementary mechanisms of Glimepiride, Metformin, and Pioglitazone, SEIZMET GP 2 offers comprehensive glycemic control, helping patients manage their blood sugar levels effectively.\n\nWhat are Glimepiride, Metformin, and Pioglitazone?\nOverview of Glimepiride\nGlimepiride is a sulfonylurea that helps control blood sugar levels by stimulating the pancreas to release more insulin. It works by closing ATP-sensitive potassium channels in the pancreatic beta cells, leading to insulin secretion.\n\nOverview of Metformin\nMetformin is a biguanide that helps lower blood sugar levels by improving the body's sensitivity to insulin and reducing the amount of glucose produced by the liver. It also enhances peripheral glucose uptake and utilization. The sustained-release formulation ensures a prolonged effect throughout the day.\n\nOverview of Pioglitazone\nPioglitazone is a thiazolidinedione (TZD) that helps improve blood sugar control by increasing the body's sensitivity to insulin. It works by activating PPARγ (peroxisome proliferator-activated receptor gamma) receptors, which regulate the transcription of insulin-responsive genes involved in the control of glucose and lipid metabolism.\n\nBenefits of SEIZMET GP 2\nEffective Blood Sugar Management\nTriple Mechanism of Action: Glimepiride stimulates insulin secretion, Metformin improves insulin sensitivity and reduces hepatic glucose production, and Pioglitazone enhances insulin sensitivity in peripheral tissues, providing a comprehensive approach to glycemic control.\nPostprandial and Fasting Glucose Control: This combination helps manage both postprandial (after-meal) and fasting blood sugar levels, offering all-around glycemic control.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: SEIZMET GP 2 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, SEIZMET GP 2 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nAdditional Health Benefits\nWeight Management: Metformin is often associated with weight neutrality or modest weight loss, making it a favorable option for overweight or obese patients.\nLipid Profile Improvement: Pioglitazone can improve lipid profiles by lowering triglycerides and increasing HDL cholesterol levels, offering additional cardiovascular benefits.\nHow to Use SEIZMET GP 2\nDosage and Administration\nRecommended Dosage: The typical dosage of SEIZMET GP 2 is one tablet taken once or twice daily, depending on your healthcare provider's instructions. The dosage may be adjusted based on individual response and blood sugar levels.\nAdministration: Take the tablet with meals to reduce the risk of gastrointestinal discomfort and enhance the effectiveness of Metformin and Pioglitazone. Swallow the tablet whole with a full glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take SEIZMET GP 2 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/seizmet-gp-2-133443", "price": 145.5, "discountamount": 43.65, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "TZD", "body", "meal", "Diet", "Order", "EMAIL", "liver", "PPARγ", "water", "amount", "Action", "option", "Support", "pancreas", "Overview", "readings", "biguanide", "overweight", "one tablet", "Guidelines", "neuropathy", "full glass", "retinopathy", "utilization", "information", "Optimal Use", "Adjustments", "Introduction", "best results", "SEIZMET GP 2", "Pioglitazone", "Metformin SR", "sterisonline", "Reduced Risk", "Postprandial", "instructions", "sterispharma", "sulfonylurea", "triglycerides", "effectiveness", "CALL/WHATSAPP", "transcription", "Administration", "obese patients", "typical dosage", "lipid profiles", "treatment plan", "Consistent Use", "Glimepiride 2mg", "lipid metabolism", "Exercise Adjunct", "prolonged effect", "Triple Mechanism", "weight neutrality", "thiazolidinedione", "excellent adjunct", "Weight Management", "insulin secretion", "peripheral tissues", "modest weight loss", "Recommended Dosage", "healthcare provider", "individual response", "blood sugar control", "insulin sensitivity", "Diabetes Management", "pancreatic beta cells", "HDL cholesterol levels", "combination medication", "cardiovascular disease", "comprehensive approach", "Fasting Glucose Control", "long-term complications", "lifestyle modifications", "complementary mechanisms", "insulin-responsive genes", "type 2 diabetes mellitus", "Lipid Profile Improvement", "peripheral glucose uptake", "stable blood sugar levels", "hepatic glucose production", "Additional Health Benefits", "gastrointestinal discomfort", "sustained-release formulation", "comprehensive glycemic control", "ATP-sensitive potassium channels", "Effective Blood Sugar Management", "additional cardiovascular benefits", "Metformin Hydrochloride Sustained Release", "peroxisome proliferator-activated receptor gamma) receptors" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1443, "imageuri": "https://productimages.withfloats.com/actual/666185c5c06ee12d88cfaefd.png", "tileimageuri": "https://productimages.withfloats.com/tile/666185c5c06ee12d88cfaefd.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T09:47:46.414Z", "updatedon": "2024-06-29T09:07:17.281Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/seizmet-gp-2-/1443", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SEIZMET GP 2 ", "category": "DIABETIC RANGE", "tags": [ "SEIZMET GP 2", "Glimepiride (2mg)", "Metformin SR (500mg)", "Pioglitazone (15mg)", "Pioglitazone side effects", "Pioglitazone 15 mg price", "Side effects of pioglitazone 15 mg", "Is pioglitazone safe", "Pioglitazone uses" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66618121a743fd2358220c35", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "SEIZMET GP 1 ", "description": "SEIZMET GP 1 \nGlimepiride (1mg), Metformin SR (500mg), Pioglitazone (15mg)\nIntroduction to SEIZMET GP 1\nSEIZMET GP 1 is a combination medication that includes Glimepiride 1mg, Metformin Hydrochloride Sustained Release (SR) 500mg, and Pioglitazone 15mg. This medication is primarily used for the management of type 2 diabetes mellitus. By combining the complementary mechanisms of Glimepiride, Metformin, and Pioglitazone, SEIZMET GP 1 offers comprehensive glycemic control, helping patients manage their blood sugar levels effectively.\n\nWhat are Glimepiride, Metformin, and Pioglitazone?\nOverview of Glimepiride\nGlimepiride is a sulfonylurea that helps control blood sugar levels by stimulating the pancreas to release more insulin. It works by closing ATP-sensitive potassium channels in the pancreatic beta cells, leading to insulin secretion.\n\nOverview of Metformin\nMetformin is a biguanide that helps lower blood sugar levels by improving the body's sensitivity to insulin and reducing the amount of glucose produced by the liver. It also enhances peripheral glucose uptake and utilization. The sustained-release formulation ensures a prolonged effect throughout the day.\n\nOverview of Pioglitazone\nPioglitazone is a thiazolidinedione (TZD) that helps improve blood sugar control by increasing the body's sensitivity to insulin. It works by activating PPARγ (peroxisome proliferator-activated receptor gamma) receptors, which regulate the transcription of insulin-responsive genes involved in the control of glucose and lipid metabolism.\n\nBenefits of SEIZMET GP 1\nEffective Blood Sugar Management\nTriple Mechanism of Action: Glimepiride stimulates insulin secretion, Metformin improves insulin sensitivity and reduces hepatic glucose production, and Pioglitazone enhances insulin sensitivity in peripheral tissues, providing a comprehensive approach to glycemic control.\nPostprandial and Fasting Glucose Control: This combination helps manage both postprandial (after-meal) and fasting blood sugar levels, offering all-around glycemic control.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: SEIZMET GP 1 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, SEIZMET GP 1 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nAdditional Health Benefits\nWeight Management: Metformin is often associated with weight neutrality or modest weight loss, making it a favorable option for overweight or obese patients.\nLipid Profile Improvement: Pioglitazone can improve lipid profiles by lowering triglycerides and increasing HDL cholesterol levels, offering additional cardiovascular benefits.\nHow to Use SEIZMET GP 1\nDosage and Administration\nRecommended Dosage: The typical dosage of SEIZMET GP 1 is one tablet taken once or twice daily, depending on your healthcare provider's instructions. The dosage may be adjusted based on individual response and blood sugar levels.\nAdministration: Take the tablet with meals to reduce the risk of gastrointestinal discomfort and enhance the effectiveness of Metformin and Pioglitazone. Swallow the tablet whole with a full glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take SEIZMET GP 1 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/seizmet-gp-1-133442", "price": 144.45, "discountamount": 43.34, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "TZD", "body", "Diet", "Order", "EMAIL", "liver", "PPARγ", "water", "meals", "amount", "Action", "option", "Support", "pancreas", "Overview", "readings", "biguanide", "neuropathy", "one tablet", "full glass", "Guidelines", "overweight", "Optimal Use", "information", "utilization", "Adjustments", "retinopathy", "Metformin SR", "SEIZMET GP 1", "best results", "Pioglitazone", "Introduction", "sterisonline", "Reduced Risk", "Postprandial", "instructions", "sterispharma", "sulfonylurea", "triglycerides", "effectiveness", "CALL/WHATSAPP", "transcription", "Administration", "obese patients", "typical dosage", "lipid profiles", "treatment plan", "Consistent Use", "Glimepiride 1mg", "lipid metabolism", "Exercise Adjunct", "prolonged effect", "Triple Mechanism", "weight neutrality", "thiazolidinedione", "excellent adjunct", "Weight Management", "insulin secretion", "peripheral tissues", "modest weight loss", "Recommended Dosage", "healthcare provider", "individual response", "blood sugar control", "insulin sensitivity", "Diabetes Management", "pancreatic beta cells", "HDL cholesterol levels", "combination medication", "cardiovascular disease", "comprehensive approach", "Fasting Glucose Control", "long-term complications", "lifestyle modifications", "complementary mechanisms", "insulin-responsive genes", "type 2 diabetes mellitus", "Lipid Profile Improvement", "peripheral glucose uptake", "stable blood sugar levels", "hepatic glucose production", "Additional Health Benefits", "gastrointestinal discomfort", "sustained-release formulation", "comprehensive glycemic control", "ATP-sensitive potassium channels", "Effective Blood Sugar Management", "additional cardiovascular benefits", "Metformin Hydrochloride Sustained Release", "peroxisome proliferator-activated receptor gamma) receptors" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1440, "imageuri": "https://productimages.withfloats.com/actual/66618124c40ee9be019ac7b4.png", "tileimageuri": "https://productimages.withfloats.com/tile/66618124c40ee9be019ac7b4.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T09:28:01.365Z", "updatedon": "2024-06-29T09:12:11.939Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/seizmet-gp-1-/1440", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SEIZMET GP 1 ", "category": "DIABETIC RANGE", "tags": [ "SEIZMET GP 1", "Glimepiride (1mg)", "Metformin SR (500mg)", "Pioglitazone (15mg)", "Pioglitazone side effects", "Pioglitazone 15 mg price", "Pioglitazone uses", "Pioglitazone 30 mg uses" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66616218a743fd235822082f", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "PIOSTERIS M 500 ", "description": "PIOSTERIS M 500 \nPioglitazone & Metformin Sustained Release Tablet\nIntroduction to PIOSTERIS M 500\nPIOSTERIS M 500 is a combination medication that includes Pioglitazone and Metformin Hydrochloride (Sustained Release). This medication is primarily used for the management of type 2 diabetes mellitus. By combining the complementary mechanisms of Pioglitazone and Metformin, PIOSTERIS M 500 offers comprehensive glycemic control, helping patients manage their blood sugar levels effectively.\n\nWhat are Pioglitazone and Metformin?\nOverview of Pioglitazone\nPioglitazone is a thiazolidinedione (TZD) that works by increasing the body's sensitivity to insulin. It helps lower blood sugar levels by making cells more responsive to insulin, enhancing glucose uptake in muscle and adipose tissue, and reducing hepatic glucose production.\n\nOverview of Metformin\nMetformin is a biguanide that helps lower blood sugar levels by improving the body's sensitivity to insulin and reducing the amount of glucose produced by the liver. It also enhances peripheral glucose uptake and utilization. The sustained-release formulation ensures a prolonged effect throughout the day.\n\nBenefits of PIOSTERIS M 500\nEffective Blood Sugar Management\nImproved Insulin Sensitivity: Pioglitazone helps improve the body's response to insulin, while Metformin enhances insulin sensitivity and reduces hepatic glucose production.\nComprehensive Glycemic Control: The combination of these two medications provides a dual mechanism of action that targets multiple pathways of glucose regulation, offering comprehensive blood sugar management.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: PIOSTERIS M 500 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, PIOSTERIS M 500 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nAdditional Health Benefits\nLipid Profile Improvement: Pioglitazone has been shown to improve lipid profiles by lowering triglycerides and increasing HDL cholesterol levels, which can provide additional cardiovascular benefits.\nSustained Blood Sugar Control: The sustained-release formulation of Metformin ensures prolonged blood sugar control throughout the day, improving patient compliance and overall effectiveness.\nHow to Use PIOSTERIS M 500\nDosage and Administration\nRecommended Dosage: The typical dosage of PIOSTERIS M 500 is one tablet taken once daily. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with meals to reduce the risk of gastrointestinal discomfort and enhance the effectiveness of Metformin. Swallow the tablet whole with a full glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take PIOSTERIS M 500 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/piosteris-m-500-134243", "price": 118.0, "discountamount": 35.4, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "TZD", "day", "body", "Diet", "meals", "EMAIL", "cells", "water", "Order", "liver", "amount", "action", "muscle", "Support", "Overview", "readings", "patients", "biguanide", "one tablet", "full glass", "neuropathy", "Guidelines", "utilization", "retinopathy", "PIOSTERIS M", "Adjustments", "information", "Optimal Use", "Introduction", "best results", "Reduced Risk", "Pioglitazone", "sterisonline", "sterispharma", "CALL/WHATSAPP", "triglycerides", "Consistent Use", "treatment plan", "dual mechanism", "typical dosage", "adipose tissue", "lipid profiles", "Administration", "two medications", "Exercise Adjunct", "prolonged effect", "excellent adjunct", "multiple pathways", "thiazolidinedione", "glucose regulation", "Recommended Dosage", "patient compliance", "Insulin Sensitivity", "healthcare provider", "individual response", "Diabetes Management", "overall effectiveness", "HDL cholesterol levels", "cardiovascular disease", "combination medication", "Metformin Hydrochloride", "long-term complications", "lifestyle modifications", "complementary mechanisms", "type 2 diabetes mellitus", "Lipid Profile Improvement", "stable blood sugar levels", "peripheral glucose uptake", "hepatic glucose production", "Additional Health Benefits", "gastrointestinal discomfort", "sustained-release formulation", "prolonged blood sugar control", "Sustained Blood Sugar Control", "comprehensive glycemic control", "Effective Blood Sugar Management", "additional cardiovascular benefits", "Metformin Sustained Release Tablet", "comprehensive blood sugar management" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1411, "imageuri": "https://productimages.withfloats.com/actual/6661621b9a0a3c2c0600b4ca.png", "tileimageuri": "https://productimages.withfloats.com/tile/6661621b9a0a3c2c0600b4ca.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T07:15:36.695Z", "updatedon": "2024-06-29T10:21:20.999Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//piosteris-m-500-/1411", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "PIOSTERIS M 500 ", "category": "DIABETIC RANGE", "tags": [ "PIOSTERIS M 500", "Pioglitazone", "Metformin Sustained Release Tablet", "Metformin hydrochloride 500 mg", "Metformin SR 500 dosage", "Metformin Hydrochloride Tablets IP 500mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6661614c870e7b20c49e4e49", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "PIOSTERIS 7.5 ", "description": "PIOSTERIS 7.5 \nPioglitazone (7.5mg)\nIntroduction to PIOSTERIS 7.5\nPIOSTERIS 7.5 contains Pioglitazone 7.5mg, a medication used primarily for the management of type 2 diabetes mellitus. Pioglitazone belongs to a class of drugs known as thiazolidinediones (TZDs), which help improve blood sugar control by increasing the body's sensitivity to insulin. This medication is typically used in combination with diet and exercise to enhance glycemic control in adults with type 2 diabetes.\n\nWhat is Pioglitazone?\nOverview of Pioglitazone\nPioglitazone is an oral diabetes medication that works by making cells more sensitive to insulin, thereby allowing the body to use insulin more effectively. This helps lower blood sugar levels in patients with type 2 diabetes. Pioglitazone can be used alone or in combination with other antidiabetic medications.\n\nMechanism of Action\nInsulin Sensitization: Pioglitazone activates peroxisome proliferator-activated receptor gamma (PPARγ) receptors, which are involved in the regulation of genes responsible for glucose and lipid metabolism. This activation increases the sensitivity of body tissues to insulin.\nGlucose Uptake: By improving insulin sensitivity, Pioglitazone enhances glucose uptake in muscle and adipose tissue and reduces hepatic glucose production, leading to lower blood sugar levels.\nBenefits of PIOSTERIS 7.5\nEffective Blood Sugar Management\nImproved Insulin Sensitivity: PIOSTERIS 7.5 helps improve the body's response to insulin, leading to better control of blood sugar levels.\nComprehensive Glycemic Control: By targeting insulin resistance, Pioglitazone provides a unique mechanism of action that complements other diabetes medications, offering comprehensive blood sugar management.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: PIOSTERIS 7.5 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, PIOSTERIS 7.5 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nAdditional Health Benefits\nLipid Profile Improvement: Pioglitazone has been shown to improve lipid profiles by lowering triglycerides and increasing HDL cholesterol levels, which can provide additional cardiovascular benefits.\nHow to Use PIOSTERIS 7.5\nDosage and Administration\nRecommended Dosage: The typical dosage of PIOSTERIS 7.5 is one tablet taken once daily. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with or without food. Swallow the tablet whole with a full glass of water. Consistency is key, so take the medication at the same time each day.\nGuidelines for Optimal Use\nConsistent Use: For best results, take PIOSTERIS 7.5 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/piosteris-7-5-133430", "price": 59.0, "discountamount": 17.7, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "food", "TZDs", "diet", "lower", "cells", "class", "water", "drugs", "EMAIL", "Order", "genes", "adults", "muscle", "Action", "Support", "readings", "Overview", "patients", "same time", "PIOSTERIS", "one tablet", "full glass", "regulation", "activation", "neuropathy", "Guidelines", "retinopathy", "combination", "Consistency", "Adjustments", "information", "Optimal Use", "best results", "Reduced Risk", "sterispharma", "body tissues", "Pioglitazone", "Introduction", "sterisonline", "triglycerides", "CALL/WHATSAPP", "typical dosage", "Administration", "treatment plan", "Consistent Use", "lipid profiles", "adipose tissue", "Glucose Uptake", "Exercise Adjunct", "lipid metabolism", "unique mechanism", "PPARγ) receptors", "excellent adjunct", "insulin resistance", "thiazolidinediones", "Recommended Dosage", "insulin sensitivity", "Diabetes Management", "blood sugar control", "healthcare provider", "individual response", "Insulin Sensitization", "cardiovascular disease", "HDL cholesterol levels", "long-term complications", "lifestyle modifications", "oral diabetes medication", "type 2 diabetes mellitus", "Lipid Profile Improvement", "stable blood sugar levels", "other diabetes medications", "Additional Health Benefits", "hepatic glucose production", "Comprehensive Glycemic Control", "other antidiabetic medications", "Effective Blood Sugar Management", "additional cardiovascular benefits", "comprehensive blood sugar management", "peroxisome proliferator-activated receptor gamma" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1410, "imageuri": "https://productimages.withfloats.com/actual/6661614f7b1fc3f9dd4c82f7.png", "tileimageuri": "https://productimages.withfloats.com/tile/6661614f7b1fc3f9dd4c82f7.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T07:12:12.153Z", "updatedon": "2024-06-29T10:23:25.301Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/piosteris-7-5-/1410", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "PIOSTERIS 7.5 ", "category": "DIABETIC RANGE", "tags": [ "PIOSTERIS 7.5", "Pioglitazone (7.5mg)", "pioz 7.5 price", "pioz 7.5 side effects", "tab pioz 7.5 uses", "pioz 7.5 tablet 10" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66615f8cccd5ce1a10758f47", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "PIOSTERIS 30 ", "description": "PIOSTERIS 30 \nPioglitazone (30mg)\nIntroduction to PIOSTERIS 30\nPIOSTERIS 30 contains Pioglitazone 30mg, a medication used primarily for the management of type 2 diabetes mellitus. Pioglitazone belongs to a class of drugs known as thiazolidinediones (TZDs), which help improve blood sugar control by increasing the body's sensitivity to insulin. This medication is typically used in combination with diet and exercise to enhance glycemic control in adults with type 2 diabetes.\n\nWhat is Pioglitazone?\nOverview of Pioglitazone\nPioglitazone is an oral diabetes medicine that works by making cells more sensitive to insulin, thereby allowing the body to use insulin more effectively. This helps lower blood sugar levels in patients with type 2 diabetes. Pioglitazone can be used alone or in combination with other antidiabetic medications.\n\nMechanism of Action\nInsulin Sensitization: Pioglitazone works by activating peroxisome proliferator-activated receptor gamma (PPARγ) receptors, which are involved in the regulation of genes responsible for glucose and lipid metabolism. This activation increases the sensitivity of body tissues to insulin.\nGlucose Uptake: By improving insulin sensitivity, Pioglitazone enhances glucose uptake in muscle and adipose tissue and reduces hepatic glucose production, leading to lower blood sugar levels.\nBenefits of PIOSTERIS 30\nEffective Blood Sugar Management\nImproved Insulin Sensitivity: PIOSTERIS 30 helps improve the body's response to insulin, leading to better control of blood sugar levels.\nComprehensive Glycemic Control: By targeting insulin resistance, Pioglitazone provides a unique mechanism of action that complements other diabetes medications, offering comprehensive blood sugar management.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: PIOSTERIS 30 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, PIOSTERIS 30 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nAdditional Health Benefits\nLipid Profile Improvement: Pioglitazone has been shown to improve lipid profiles by lowering triglycerides and increasing HDL cholesterol levels, which can provide additional cardiovascular benefits.\nHow to Use PIOSTERIS 30\nDosage and Administration\nRecommended Dosage: The typical dosage of PIOSTERIS 30 is one tablet taken once daily. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with or without food. Swallow the tablet whole with a full glass of water. Consistency is key, so take the medication at the same time each day.\nGuidelines for Optimal Use\nConsistent Use: For best results, take PIOSTERIS 30 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/piosteris-30-134190", "price": 95.0, "discountamount": 28.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "TZDs", "diet", "food", "cells", "genes", "water", "Order", "class", "EMAIL", "drugs", "muscle", "adults", "Action", "Support", "readings", "Overview", "patients", "same time", "PIOSTERIS", "full glass", "Guidelines", "neuropathy", "one tablet", "activation", "regulation", "Optimal Use", "combination", "information", "Adjustments", "Consistency", "retinopathy", "sterisonline", "sterispharma", "best results", "Introduction", "Reduced Risk", "body tissues", "CALL/WHATSAPP", "triglycerides", "Administration", "typical dosage", "lipid profiles", "treatment plan", "Consistent Use", "Glucose Uptake", "adipose tissue", "Exercise Adjunct", "PPARγ) receptors", "unique mechanism", "lipid metabolism", "excellent adjunct", "Pioglitazone 30mg", "insulin resistance", "thiazolidinediones", "Recommended Dosage", "insulin sensitivity", "healthcare provider", "Diabetes Management", "individual response", "blood sugar control", "Insulin Sensitization", "cardiovascular disease", "HDL cholesterol levels", "oral diabetes medicine", "lifestyle modifications", "long-term complications", "type 2 diabetes mellitus", "lower blood sugar levels", "stable blood sugar levels", "Lipid Profile Improvement", "other diabetes medications", "Additional Health Benefits", "hepatic glucose production", "Comprehensive Glycemic Control", "other antidiabetic medications", "Effective Blood Sugar Management", "additional cardiovascular benefits", "comprehensive blood sugar management", "peroxisome proliferator-activated receptor gamma" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1407, "imageuri": "https://productimages.withfloats.com/actual/66615f8f8e77bb2c715607af.png", "tileimageuri": "https://productimages.withfloats.com/tile/66615f8f8e77bb2c715607af.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T07:04:44.526Z", "updatedon": "2024-06-29T10:30:40.061Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//piosteris-30-/1407", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "PIOSTERIS 30 ", "category": "DIABETIC RANGE", "tags": [ "PIOSTERIS 30", "Pioglitazone (30mg)", "Pioglitazone 30mg uses", "Pioglitazone 30mg side effects", "Pioglitazone dose", "pioglitazone price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66615b6e161afa2274ff47c8", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "PIOSTERIS 15 ", "description": "PIOSTERIS 15 \nPioglitazone (15mg)\nIntroduction to PIOSTERIS 15\nPIOSTERIS 15 contains Pioglitazone 15mg, a medication used primarily for the management of type 2 diabetes mellitus. Pioglitazone belongs to a class of drugs known as thiazolidinediones (TZDs), which help improve blood sugar control by increasing the body's sensitivity to insulin. This medication is typically used in combination with diet and exercise to enhance glycemic control in adults with type 2 diabetes.\n\nWhat is Pioglitazone?\nOverview of Pioglitazone\nPioglitazone is an oral diabetes medicine that works by making cells more sensitive to insulin, thereby allowing the body to use insulin more effectively. This helps lower blood sugar levels in patients with type 2 diabetes. Pioglitazone can be used alone or in combination with other antidiabetic medications.\n\nMechanism of Action\nInsulin Sensitization: Pioglitazone works by activating peroxisome proliferator-activated receptor gamma (PPARγ) receptors, which are involved in the regulation of genes responsible for glucose and lipid metabolism. This activation increases the sensitivity of body tissues to insulin.\nGlucose Uptake: By improving insulin sensitivity, Pioglitazone enhances glucose uptake in muscle and adipose tissue and reduces hepatic glucose production, leading to lower blood sugar levels.\nBenefits of PIOSTERIS 15\nEffective Blood Sugar Management\nImproved Insulin Sensitivity: PIOSTERIS 15 helps improve the body's response to insulin, leading to better control of blood sugar levels.\nComprehensive Glycemic Control: By targeting insulin resistance, Pioglitazone provides a unique mechanism of action that complements other diabetes medications, offering comprehensive blood sugar management.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: PIOSTERIS 15 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, PIOSTERIS 15 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nAdditional Health Benefits\nLipid Profile Improvement: Pioglitazone has been shown to improve lipid profiles by lowering triglycerides and increasing HDL cholesterol levels, which can provide additional cardiovascular benefits.\nHow to Use PIOSTERIS 15\nDosage and Administration\nRecommended Dosage: The typical dosage of PIOSTERIS 15 is one tablet taken once daily. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with or without food. Swallow the tablet whole with a full glass of water. Consistency is key, so take the medication at the same time each day.\nGuidelines for Optimal Use\nConsistent Use: For best results, take PIOSTERIS 15 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/piosteris-15-133429", "price": 55.0, "discountamount": 16.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "TZDs", "diet", "food", "cells", "genes", "water", "Order", "class", "EMAIL", "drugs", "muscle", "adults", "Action", "Support", "readings", "Overview", "patients", "same time", "PIOSTERIS", "full glass", "Guidelines", "neuropathy", "one tablet", "activation", "regulation", "Optimal Use", "combination", "information", "Adjustments", "Consistency", "retinopathy", "sterisonline", "sterispharma", "best results", "Introduction", "Reduced Risk", "body tissues", "CALL/WHATSAPP", "triglycerides", "Administration", "typical dosage", "lipid profiles", "treatment plan", "Consistent Use", "Glucose Uptake", "adipose tissue", "Exercise Adjunct", "PPARγ) receptors", "unique mechanism", "lipid metabolism", "excellent adjunct", "Pioglitazone 15mg", "insulin resistance", "thiazolidinediones", "Recommended Dosage", "insulin sensitivity", "healthcare provider", "Diabetes Management", "individual response", "blood sugar control", "Insulin Sensitization", "cardiovascular disease", "HDL cholesterol levels", "oral diabetes medicine", "lifestyle modifications", "long-term complications", "type 2 diabetes mellitus", "lower blood sugar levels", "stable blood sugar levels", "Lipid Profile Improvement", "other diabetes medications", "Additional Health Benefits", "hepatic glucose production", "Comprehensive Glycemic Control", "other antidiabetic medications", "Effective Blood Sugar Management", "additional cardiovascular benefits", "comprehensive blood sugar management", "peroxisome proliferator-activated receptor gamma" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1406, "imageuri": "https://productimages.withfloats.com/actual/66615b718e77bb2c7155ff9e.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/66615b718e77bb2c7155ff9e.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T06:47:10.939Z", "updatedon": "2024-06-29T10:35:49.49Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/piosteris-15-/1406", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "PIOSTERIS 15 ", "category": "DIABETIC RANGE", "tags": [ "PIOSTERIS 15", "Pioglitazone (15mg)", "Pioglitazone 15 mg uses", "Pioglitazone side effects", "Pioglitazone dose", "Pioglitazone hydrochloride" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "665ef7cfea22b014e8aefff9", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLICLAGLAZE MR 30 ", "description": "GLICLAGLAZE MR 30 \ngliclazide sr (30 mg)\nIntroduction\nGLICLAGLAZE MR 30 is specifically formulated for individuals managing Type 2 diabetes. This medication utilizes a sustained release (SR) form of Gliclazide at a 30 mg dosage, focusing on providing a steady, controlled release of the drug to maintain optimal blood sugar levels throughout the day.\n\nHow It Works\n\nGliclazide SR (30 mg): Gliclazide is a sulfonylurea class drug that increases insulin secretion from the pancreas. Unlike standard formulations, the SR version releases the medication gradually, which helps to stabilize blood sugar levels and reduces the risk of severe fluctuations that can lead to hypoglycemia. This mechanism not only enhances the body’s natural insulin use but also supports overall vascular health, decreasing the risk of complications associated with diabetes, such as cardiovascular disease.\nBenefits\nGLICLAGLAZE MR 30 is an excellent choice for patients who require a mild enhancement in their insulin secretion with a lower risk of hypoglycemia. The SR formulation provides a more predictable pharmacokinetic profile, which is crucial for maintaining a stable glycemic control. This can significantly improve the quality of life for patients by reducing common side effects associated with blood sugar spikes and drops.\n\nDosage and Administration\n\nDosage: The dose of GLICLAGLAZE MR 30 should be adjusted based on the patient’s blood glucose response and previous treatment history. Regular monitoring of blood glucose and glycated hemoglobin (HbA1c) levels is recommended to ensure that the dosage is effective.\nAdministration: This medication should be taken with breakfast or the first main meal of the day. The tablet should be swallowed whole to maintain the integrity of the sustained release mechanism.\nSide Effects\nPossible side effects of GLICLAGLAZE MR 30 include gastrointestinal issues such as nausea and upset stomach. Due to its sulfonylurea component, there is a risk of hypoglycemia, although it is generally lower compared to other sulfonylureas due to the sustained release formulation.\n\nConclusion\nGLICLAGLAZE MR 30 is a practical and effective solution for managing Type 2 diabetes, especially suited for patients seeking a gentle modification in their diabetes treatment plan with sustained drug release. It simplifies diabetes management, potentially enhancing adherence and minimizing the risk of dosage-related complications. As with any medication, consultation with a healthcare provider is essential to tailor the treatment to individual needs and conditions.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/gliclaglaze-mr-30-133422", "price": 83.0, "discountamount": 24.9, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "dose", "life", "body", "drops", "EMAIL", "Order", "upset", "tablet", "nausea", "stomach", "quality", "SR) form", "patients", "Benefits", "pancreas", "adherence", "integrity", "breakfast", "practical", "lower risk", "SR version", "medication", "conditions", "Conclusion", "individuals", "information", "sterisonline", "Introduction", "30 mg dosage", "consultation", "sterispharma", "hypoglycemia", "CALL/WHATSAPP", "Gliclazide SR", "HbA1c) levels", "SR formulation", "GLICLAGLAZE MR", "first main meal", "Type 2 diabetes", "mild enhancement", "individual needs", "excellent choice", "insulin secretion", "effective solution", "Regular monitoring", "blood sugar spikes", "healthcare provider", "diabetes management", "gentle modification", "other sulfonylureas", "common side effects", "glycated hemoglobin", "severe fluctuations", "natural insulin use", "Possible side effects", "standard formulations", "Administration Dosage", "sulfonylurea component", "sustained drug release", "blood glucose response", "cardiovascular disease", "diabetes treatment plan", "stable glycemic control", "gastrointestinal issues", "overall vascular health", "sulfonylurea class drug", "steady, controlled release", "optimal blood sugar levels", "previous treatment history", "sustained release mechanism", "dosage-related complications", "sustained release formulation", "predictable pharmacokinetic profile" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1291, "imageuri": "https://productimages.withfloats.com/actual/665ef7d253245b8b6b459895.png", "tileimageuri": "https://productimages.withfloats.com/tile/665ef7d253245b8b6b459895.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-04T11:17:35.736Z", "updatedon": "2024-06-04T11:17:35.736Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/gliclaglaze-mr-30-/1291", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLICLAGLAZE MR 30 ", "category": "DIABETIC RANGE", "tags": null, "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }